UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000018826
Receipt No. R000021737
Official scientific title of the study Clinical setting of photodynamic therapy for the allergic rhinitis
Date of disclosure of the study information 2015/09/01
Last modified on 2016/09/26 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Clinical setting of photodynamic therapy for the allergic rhinitis
Title of the study (Brief title) Photodynamic therapy for the allergic rhinitis
Region
Japan

Condition
Condition Allergic rhinitis
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Safety
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes complication
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Maneuver
Interventions/Control_1 Photodynamic therapy for one day
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria Patients of perennial allergic rhinitis over 2 consecutive years
Patients having specific antibody (mite and/or house dust) over class 2 (ImmunoCap)
Positive for skin prick test
Key exclusion criteria Having the medicine that would couse photosensitivity
Having hepatic dysfunction, renal dysfunction or cardiac dysfunction
porphyria patient
Target sample size 12

Research contact person
Name of lead principal investigator Yoshitaka Okamoto
Organization Graduate School of Medicine, Chiba University
Division name Otolaryngology, Head and Neck Surgery
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan
TEL +81-43-226-2137
Email ttn3hyi@yahoo.co.jp

Public contact
Name of contact person Takeshi Suzuki
Organization Graduate School of Medicine, Chiba University
Division name Otolaryngology, Head and Neck Surgery
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan
TEL +81-43-226-2137
Homepage URL
Email ttn3hyi@yahoo.co.jp

Sponsor
Institute Graduate School of Medicine, Chiba University
Institute
Department

Funding Source
Organization Grant-in-Aid for Young Scientists(B)
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 09 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 08 Month 11 Day
Anticipated trial start date
2015 Year 10 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 08 Month 27 Day
Last modified on
2016 Year 09 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021737